English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Myeloid cell leukemia 1 (Mcl-1) is an anti-apoptotic protein which is overexpressed in various leukemia and other cancers [1]. Mcl-1 has a very short half-life [2], which has been suggested as a molecular mechanism for cells to switch into either the survival or apoptotic pathways in response to different stresses [3]. Recently, it has been demonstrated that downregulation of Mcl-1 by various pharmacological agents or genetic approaches dramatically increases ABT-737 lethality in various malignant cell types [4]. Different strategies for targeting Mcl-1 include (i) small interfering RNA [5] (ii) small-molecule inhibitors [6] and (iii) peptide inhibitors [7]. In recent years, therapeutic vaccination with synthetic peptides derived from anti-apoptotic proteins such as Mcl-1 has emerged as a promising strategy against hematological cancers. In this study, 34 overlapping 20-mer peptides, spanning the entire Mcl-1 protein, were adjuvanted with cationic liposomes [8] and tested in three different mouse strains with varied Major Histocompatibility Complex (MHC) haplotypes (FVB [H-2q], CB6F1[H-2b/d], B6CBAF1 [H-2b/k]) to identify immunogenic CD4+ T-cell epitopes.

Identifying Immunogenic CD4+ T-Cell Epitopes of Myeloid Cell Leukemia 1 Using Overlapping 20-mer Peptides Spanning the Whole Protein